Lv2
166 积分 2024-08-27 加入
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
19小时前
已完结
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
24天前
已完结
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
25天前
已完结
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
25天前
已完结
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
25天前
已完结
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
25天前
已完结
Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
25天前
已完结
胰高糖素样肽-1受体激动剂利拉鲁肽在糖尿病患者中的应用
25天前
已完结
Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes
25天前
已完结
国产利拉鲁肽注射液治疗2型糖尿病的疗效和安全性：一项多中心随机对照等效性研究
25天前
已完结
皖公网安备34019202002308
